The new Research Programs of Faculty of Medicine have been chosen

Based on , the Faculty of Medicine has approved the following nine Research programs. All programs are approved for six years. Some of the programs will have a a mid-term written review at the end of 2021.

Applied Tumor Genomics (ATG)

Group leader:

16 members (9 Principal Investigators, 4 Associated Clinical Researchers, 3 Junior Researchers)

Clinical and Molecular Metabolism (CAMM)

Group leader:

26 members (10 Principal Investigators, 11 Associated Clinical Researchers, 5 Junior Researchers)

Human Microbiome Research

Group leader:

19 members (7 Principal Investigators, 9 Associated Clinical Researchers, 3 Junior Researchers)

Individualized Drug Therapy (INDIVIDRUG)

Group leader:

15 members (11 Principal Investigators, 3 Associated Clinical Researchers, 1 Junior Researchers)

Program in Translational Immunology (TRIMM)

Group leader:

23 members (10 Principal Investigators, 11 Associated Clinical Researchers, 2 Junior Researchers)

Sleep and stress in health and in transition from acute to chronic diseases (SLEEPWELL)

Group leader:

14 members (8 Principal Investigators, 4 Associated Clinical Researchers, 2 Junior Researchers)

Systems Oncology (ONCOSYS)

Group leader:

19 members (10 Principal Investigators, 6 Associated Clinical Researchers, 3 Junior Researchers)

Translational Cancer Medicine Program (CAN-PRO)

Group leader:

19 members (12 Principal Investigators, 2 Associated Clinical Researchers, 5 Junior Researchers)

Translational Stem Cell Biology and Metabolism (STEMM)

Group leader:

16 members (11 Principal Investigators, 4 Associated Clinical Researchers, 1 Junior Researchers)

Altogether twelve research program candidates participated in the scientific evaluation. The negotiations on space allocations and other resources will take place in the fall 2018 with the chosen nine Research Programs.

More information: